50 results
DEFM14A
SQZB
SQZ Biotechnologies Co
23 Jan 24
Proxy related to merger
4:31pm
to be conducted. The holders of a majority in voting power of the Company’s Common Stock issued and outstanding and entitled to vote, present in person … . If a quorum is not present or represented at the scheduled time of the Special Meeting, (i) the chairperson of the Special Meeting or (ii) a majority
PREM14A
SQZB
SQZ Biotechnologies Co
12 Jan 24
Preliminary proxy related to merger
8:57am
Meeting for any business to be conducted. The holders of a majority in voting power of the Company’s Common Stock issued and outstanding and entitled … or (ii) a majority in voting power of the stockholders entitled to vote thereon, present in person, including by remote communication, or represented
8-K
EX-2.1
SQZB
SQZ Biotechnologies Co
22 Dec 23
Entry into a Material Definitive Agreement
5:18pm
interests having the power to elect a majority of that corporation’s or other Person’s board of directors or similar governing body, or otherwise having
8-K
SQZB
SQZ Biotechnologies Co
2 Oct 23
Cost Associated with Exit or Disposal Activities
5:17pm
period to the affected employees, approximately $100,000 of which is anticipated to result in cash expenditures. The Company expects that the majority
PRE 14A
a6ff2btsmcxy
10 Apr 23
Preliminary proxy
4:31pm
8-K
EX-99.2
bppmyi
9 Dec 21
Other Events
7:30am
8-K
EX-99.3
f58eb i6t
9 Dec 21
Other Events
7:30am
S-3
EX-4.3
bvcklwm66hk1ymift62
12 Nov 21
Shelf registration
12:00am
S-3
urz9vh0h 7t
12 Nov 21
Shelf registration
12:00am
DEF 14A
gqx0mk05l931hv762
26 Apr 21
Definitive proxy
5:00pm
10-K
EX-4.3
yb4l6fx 3q
18 Mar 21
Annual report
6:31am
10-K
3ah feb1242v
18 Mar 21
Annual report
6:31am